Gaingels

Cofertility is a human-centered fertility ecosystem that provides egg donation and egg-freezing services for fertility care and third-party reproduction.

VerImmune, based in Baltimore, Maryland, is an immuno-oncology company focused on developing innovative cancer therapies through its proprietary technology, Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This unique approach aims to harness pre-existing immune memory from pathogens or childhood vaccines to target and redirect the immune system toward tumors. By doing so, VerImmune seeks to address significant challenges in cancer treatment, particularly for patients with limited options or those who have developed resistance to conventional therapies. The company's strategy promises to offer low toxicity and sustained benefits across a diverse range of cancer types, potentially transforming the treatment landscape for those with difficult-to-treat malignancies.

Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized support for families and employees managing the care of aging adults and children. Established in 2019, Grayce offers a comprehensive range of services, including assistance with insurance, finances, legal plans, medical care, home care, housing, and daily needs. The company emphasizes individualized guidance, ensuring that each member receives dedicated support from a social worker who helps manage their overall care. This includes planning, resource identification, care coordination, and advocacy, empowering family caregivers to effectively navigate the complexities of caring for their loved ones.

OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the barriers posed by tumors. By enhancing the effectiveness and durability of immunotherapies, OverT Bio aims to advance the healthcare field's ability to identify and ultimately cure cancer.

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.

Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.

Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Ezra AI, Inc. specializes in developing artificial intelligence technology-based investigational devices aimed at early cancer detection. The company utilizes full-body MRI scans enhanced by AI to innovate cancer screening methods. Its initial product, an AI software designed to assist radiologists in interpreting prostate MRI images, has received FDA clearance as a medical device. Founded in 2017, Ezra AI is headquartered in New York, New York, and primarily serves customers in New York and California.

Parsley Health, Inc. offers personalized holistic healthcare services focused on addressing the root causes of diseases. By considering patients' personal histories, lifestyles, environments, and genetic factors, the company creates comprehensive health regimens that may include dietary changes, lifestyle adjustments, stress management techniques, supplements, botanical medicines, and prescription drugs. Their services encompass functional medicine assessments, personalized nutrition consultations, health coaching, specialized testing, bioidentical hormone therapy, and online access to labs and medical records. Parsley Health also provides various diagnostic tests and sells health-related products online. Founded in 2015 by Dr. Robin Berzin, M.D., the company operates clinics in New York City, Los Angeles, and San Francisco, integrating technology with wellness and preventive care to offer a subscription-based model that emphasizes chronic disease management and personalized treatment.

Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Pair Team focuses on enhancing primary care infrastructure for vulnerable communities, particularly those served by safety-net systems, Medicaid, and Medicare patients. As a tech-enabled care team, it extends the capabilities of clinical staff by offering personalized, high-touch care experiences. The organization addresses various barriers to healthcare, including transportation issues, housing and food insecurity, and limited mobile access. Pair Team employs a dedicated care team consisting of community health workers, registered nurses, and behavioral health clinicians to deliver comprehensive support tailored to the needs of low-income individuals. Additionally, the company is developing a care delivery platform designed to implement clinical best practices, integrate services with community-based organizations, and streamline administrative tasks, allowing clinicians to dedicate more time to patient care.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

VerImmune, based in Baltimore, Maryland, is an immuno-oncology company focused on developing innovative cancer therapies through its proprietary technology, Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This unique approach aims to harness pre-existing immune memory from pathogens or childhood vaccines to target and redirect the immune system toward tumors. By doing so, VerImmune seeks to address significant challenges in cancer treatment, particularly for patients with limited options or those who have developed resistance to conventional therapies. The company's strategy promises to offer low toxicity and sustained benefits across a diverse range of cancer types, potentially transforming the treatment landscape for those with difficult-to-treat malignancies.

Carenostics is a health technology company focused on addressing the underdiagnosis, undertreatment, and health inequities associated with chronic diseases. The company employs artificial intelligence and machine learning to analyze patient data collected during routine care. Its detection models integrate seamlessly into providers' electronic health records (EHRs), allowing for the identification of chronic conditions that may have gone undiagnosed. By projecting the potential decline of patients with these conditions, Carenostics enables healthcare providers to prioritize care for individuals who need it most, ultimately aiming to improve health outcomes and reduce disparities in chronic disease management.

Superluminal Medicines is a generative biological and chemical company accelerating new possibilities in drug discovery and development. Its platform quickly creates candidate-ready compounds using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. They leverage cutting-edge computational and machine-learning techniques to accelerate identifying and optimizing novel drug candidates. Their approach combines high-throughput experimental data with advanced algorithms to uncover therapeutic compounds faster and more efficiently than traditional methods.

Remedial Health operates as a wholesale distributor of medicine, catering to the vast network of approximately one million pharmacies and hospitals across Africa. The company addresses the prevalent inefficiencies in the healthcare supply chain, where providers often depend on open-air markets to acquire pharmaceuticals, leading to risks of counterfeit products. By offering a pharmacy operations and procurement management platform, Remedial Health enhances business-to-business access to medications. This platform incorporates technology that simplifies the ordering process and facilitates direct access to retail medicines from manufacturers or distributors, thereby improving workflow management and ensuring a more reliable supply of genuine medications for healthcare providers.

Alnair Therapeutics is a preclinical stage precision oncology platform dedicated to developing innovative treatments for difficult-to-treat malignancies. The company has pioneered a unique drug delivery technology that utilizes the distinct characteristics of cancer metabolism to enhance the targeting and penetration of therapeutic agents directly into cancer cells. This approach aims to improve treatment outcomes for patients, positioning Alnair Therapeutics as a potential leader in the field of cancer treatment.

SpecCheck is an optical platform that offers comprehensive solutions for eye care specialists. It facilitates accurate prescription eyewear ordering and tracking, seamless billing, and improved communication among patients, eye doctors, and optical labs. By streamlining these processes, SpecCheck enables its users to enhance productivity and reduce costly errors, ultimately improving overall workflow in the eye care sector.

Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematological cancers. They will then attack solid tumors using the special benefits of their cellular source.

Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.

Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.

Sequencing is the world’s first and only open operating system for DNA sequencing, storage, analysis, personalization, and application development. We are ushering in a new era of personal genome innovation for consumers, bioinformatics developers/startups, pharmaceutical companies, and health and wellness providers. Sequencing has been used by partners throughout the world to develop and market more than 100 DNA analysis apps. These apps analyze data from our own or any third party genetic test (including 23andMe, Ancestry.com, Illumina, Invitae, and Color) and provide straightforward reports covering the full range of information that can be obtained from DNA including personalized medicine, preventive health, preconception screening, rare disease screening, wellness optimization, genealogy, and genetic data exploration. Our DNA-as-a-service enables healthcare providers and wellness organizations to effortlessly customize their own genetic testing, analysis, and storage pipelines for almost any purpose, including the assessment of risk for thousands of diseases, the likelihood of experiencing medication reactions, and the personalization of wellness products and services.

Gabbi is a healthcare software company focused on empowering women to better understand their health and take proactive steps in managing it. The platform utilizes artificial intelligence and clinical research to create a proprietary risk model that assesses a woman's lifetime risk of various diseases. Gabbi provides personalized and interactive action plans, along with tools for community engagement and support. Key features include a risk calculator specifically designed for breast cancer, virtual chat options, community support, and video appointments. By fostering a supportive environment and offering tailored health insights, Gabbi aims to reduce the incidence of preventable diseases and improve early diagnosis for women.

Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.

VerImmune, based in Baltimore, Maryland, is an immuno-oncology company focused on developing innovative cancer therapies through its proprietary technology, Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This unique approach aims to harness pre-existing immune memory from pathogens or childhood vaccines to target and redirect the immune system toward tumors. By doing so, VerImmune seeks to address significant challenges in cancer treatment, particularly for patients with limited options or those who have developed resistance to conventional therapies. The company's strategy promises to offer low toxicity and sustained benefits across a diverse range of cancer types, potentially transforming the treatment landscape for those with difficult-to-treat malignancies.

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Kindly Health is a diagnostics platform for sexual care and performance health. Kindly Health offers complete solutions for sperm health and sexual performance in men, as well as low libido, PCOS, irregular periods, and menstrual pain in women. Kindly Health makes it more accessible by combining at-home diagnostic tests (including semen tests and polycystic ovary syndrome tests), telehealth consultations, and supplements.

Choiz operates a healthcare platform designed to provide personalized medical treatments directly to patients in their homes. The service encompasses a comprehensive, end-to-end healthcare experience, which includes diagnosis, medication delivery, and ongoing care. By connecting patients with health professionals and facilitating the timely delivery of necessary medications, Choiz aims to make specialized care and treatment more accessible to everyone. The platform is built with a patient-centric approach, ensuring that individual needs are met throughout the healthcare journey.

Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Boulder is a digital health platform expanding access to effective treatment for opiate use. We aim to move the behavioral health industry forward by offering dramatically better experiences for patients and their care teams.

Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.

Nelly provides a tool for medical practices that simplifies patient onboarding and payments. It creates the basis for stress-free and clear work in your practice by drastically reducing the administrative effort for doctors, MFAs, ZFAs, and patients with Nelly. 90% of all healthcare professionals perceive bureaucracy and administrative burdens as the biggest problem in the workplace. The company's mission is to reduce the administrative effort in the healthcare sector by simplifying documentation and payment processes in order to make the practice visit more patient- and employee-friendly.

Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.

Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.

Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

CareAlign offers a patient-centric task management tool that assists clinicians in tracking, managing, and coordinating clinical care. The platform provides an intuitive interface for assigning tasks with specific dates and times, categorizing them by urgency, and reviewing completed tasks. Additionally, CareAlign has developed a real-time data system that consolidates information from various sources into a cohesive and easily navigable display. This system enhances clinicians' understanding of patients' clinical statuses, ultimately improving care coordination.

OxiWear develops innovative ear-wearable devices that provide continuous oxygen monitoring and emergency alerts to help detect and prevent silent hypoxia, particularly in individuals with pulmonary hypertension, those at high altitudes, or engaged in high-intensity activities, including during COVID-19. The company's patented pulse oximeter is designed for both clinical and consumer use, allowing patients to monitor their oxygen levels effectively. By offering real-time monitoring and alerts, OxiWear enhances patient safety and peace of mind, ensuring that individuals can obtain timely medical assistance when necessary.

Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.

Zeit Medical provides therapy for neurological injuries by identifying signature patterns in EEG and enables physicians to diagnose and treat with precision. The company was founded in 20202019 by Urs Naber and Orestis Vardoulis.

Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Karma Biotechnologies, Inc. is a Los Angeles-based startup focused on developing therapies for autoimmune diseases, allergies, and food sensitivities. Founded in 2019, the company offers Xavines, a precision immunotherapy platform designed to address the critical need for antigen-specific therapies that target only the rogue immune cells responsible for these conditions. Unlike traditional treatments that rely on general immune suppression, Karma Biotechnologies aims to create tolerogenic immunotherapies that promote antigen-specific immune tolerance in vivo. By leveraging its expertise in immunology and lipid nanoparticle engineering, the company seeks to provide innovative solutions that enhance the treatment landscape for autoimmune diseases and related disorders.

EIO Diagnostics Inc. is a Canadian company specializing in mastitis detection systems for dairy cattle. Founded in 2017 and based in Duncan, the company has developed the FirstLook Mastitis system, which employs a multispectral sensor to capture images of the udder as cows enter the milk parlor. This technology utilizes infrared image analysis and computer vision to automate the detection of early indicators of mastitis, allowing farmers to prevent infections before they occur. By installing a single sensor at the entry of the rotary milking system, EIO Diagnostics enables farmers to monitor udder health efficiently, thereby enhancing livestock health and improving milk quality while reducing labor and associated costs.

Ruth Health is a telehealth facility focused on women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. By utilizing evidence-based expertise, the company enhances access to childbirth services, making them more affordable and enjoyable. Ruth Health's platform offers medical consultations and information on postpartum care, addressing common women's health issues such as painful sex and unwanted urination. It also provides at-home ultrasound services and online consultations with healthcare professionals, enabling women to take control of their health and confidently navigate family planning and parenthood.

Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

Oath Care is developing an innovative model of group-based, continuous healthcare aimed at enhancing health outcomes for children. The company operates an online platform that connects medical providers with families, fostering intimate connections and shared parental experiences. Through this platform, users can access specialist support and guidance via group chats and one-on-one video calls. This approach allows patients to receive tailored medical and emotional support, addressing their individual needs effectively.

American Gene Technologies (AGT) specializes in developing innovative gene therapies aimed at curing serious diseases, including infectious diseases, cancers, and inherited disorders. The company is advancing its proprietary gene-delivery platform, which is backed by multiple patents, including those for its AGT103-T cell product designed to functionally cure HIV. AGT is also focused on a unique immuno-oncology approach that stimulates gamma-delta T cells to target various solid tumors. Additionally, the company has developed a synthetic gene to provide effective treatments for Phenylketonuria (PKU). AGT’s clinical trial for an HIV cure has the potential to not only address a significant public health challenge but also validate its technology platform for treating a variety of diseases.

ELANZA Wellness is a virtual chronic care platform designed specifically for individuals with endometriosis and other chronic reproductive health conditions. The platform aims to provide comprehensive support by offering access to medical specialists, evidence-based therapies, and personalized treatment plans that promote symptom relief. ELANZA Wellness focuses on a whole-person care approach, developed by multidisciplinary teams, to ensure that patients feel heard and understood throughout their healthcare journey. By enabling users to access therapeutic programs and make informed lifestyle changes, the platform empowers individuals to take control of their health and well-being, ultimately fostering a better quality of life.

Brave Care, Inc. specializes in urgent pediatric health care services, treating a wide range of conditions, including allergies, asthma, cough, ear pain, eye issues, fever, minor fractures, and rashes. The company also offers pediatric-specific laboratory services, on-site x-ray, and light sedation for certain procedures. Founded in 2019 and based in Portland, Oregon, Brave Care operates clinics exclusively designed for children in Oregon and Texas. In addition to in-person care, the BraveCare.com website and mobile app provide nationwide pediatric advice to assist parents in supporting their children's health and development.

Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.

Kit is a company focused on providing at-home medical exams and health testing services. It develops comprehensive health testing kits that enable insurers and telehealth companies to offer convenient and safe testing options for their patients from the comfort of their homes. These kits serve as a reliable alternative to traditional doctor and laboratory visits, making preventative health testing accessible across various industries. As a subsidiary of Ro, Kit is committed to enhancing the healthcare experience through innovative solutions.

Dock Health is a HIPAA compliant task management and collaboration platform designed for healthcare. The company is focused on solving some of the most pressing issues in healthcare by making communication and collaboration easier through thoughtful design and simplicity. Dock is on a mission to solve the workflow challenges and inefficiencies for clinicians and their teams. Dock Health hopes to improve patient care by giving medical teams a reliable and secure system to ensure the work gets done. Founded in 2016, Dock Health is headquartered in Boston, Massachusetts.

In the next decade, expect a revolutionary redesign of healthcare for instant guidance. Starting from joint & muscle care, Nora is the first AI knowledge assistant that delivers precise and medically sound guidance right when you need it. Leveraging a seamless fusion of conversational AI and proprietary computer vision models to automatize patient intake and physical examination, we unlock immediate guidance and care access for acute pain in less than 10 minutes.

Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this is only the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care.

Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.

Cerebral Inc. is a mental health telemedicine company that provides an online membership platform for telehealth visits and care counseling services. Founded in 2019 and headquartered in Walnut, California, Cerebral offers comprehensive support for individuals experiencing anxiety, depression, and insomnia. The platform facilitates medication management, counseling, and therapy, ensuring access to regular visits and communication with care counselors. It employs clinically proven symptom-based ratings and tracking methods to enhance patient care. By prioritizing accessibility and affordability, Cerebral aims to democratize high-quality mental health care, allowing patients to receive timely and effective treatment while following evidence-based guidelines throughout their wellness journey.

Included Health is a healthcare company that offers a blend of virtual care, navigation, and community-based services aimed at enhancing the overall healthcare experience. By integrating technology with personalized care, the company provides members with guidance and advocacy for a wide range of health needs, including urgent and primary care, behavioral health, and specialty services. Included Health focuses on ensuring that individuals receive the appropriate care at the right time, utilizing compassionate and data-driven approaches to improve clinical outcomes and member satisfaction. Through its innovative model, Included Health seeks to redefine healthcare accessibility and quality for all individuals.

SISU Aesthetic Clinic operates a network of doctor-led, patient-centric medical clinics focused on delivering non-invasive aesthetic treatments. The clinic specializes in a range of personalized beauty services, including anti-wrinkle injections, lip fillers, facials, excessive sweat care, silhouette soft restoration, dermal fillers, and profile treatments. By prioritizing an empathetic approach to care, SISU aims to enhance patients' skin health and overall well-being, enabling them to lead quality lives.

Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

Vidya Health is the medical technology company based in London

Phosphorus, Inc. is a clinical genetic testing company that specializes in developing diagnostic kits to identify inherited risks for various diseases, including cancer, heart disease, and vision loss. The company's offerings include PhosphorusONE, a genetic testing kit, along with specialized tests such as HeartMap for hereditary heart conditions and LipidMap for hereditary high cholesterol. Phosphorus also provides panel-based genetic testing across multiple medical fields, including fertility, cardiology, oncology, and neurology, as well as a COVID-19 saliva testing kit. The company utilizes next-generation sequencing technology to ensure high-quality, actionable results and operates a CLIA and CAP certified laboratory, allowing it to conduct tests in all 50 states. Additionally, Phosphorus offers a software platform called Element for managing genetic test data and provides research services. The company, founded in 2016 and headquartered in New York, New York, sells its products online and partners with healthcare providers and hospitals to enhance the integration of genetics in medical care.

Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.

Boulder is a digital health platform expanding access to effective treatment for opiate use. We aim to move the behavioral health industry forward by offering dramatically better experiences for patients and their care teams.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

NKGen Biotech, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing innovative cell therapies using Natural Killer (NK) cells. The company focuses on creating autologous, allogeneic, and CAR-NK cell therapeutics to target neurodegenerative and oncological diseases. Utilizing proprietary technologies for cell expansion and activation, NKGen Biotech can significantly enhance the cytotoxic capabilities of NK cells, enabling their effective use in treating abnormal or diseased cells. Their product candidates, particularly the SuperNKTM (SNK) cells, are developed through a unique manufacturing and cryopreservation process that has demonstrated increased activity in laboratory settings. This advancement in NK cell therapy positions NKGen Biotech at the forefront of innovative treatments aimed at harnessing the human innate immune response.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Augmedix, Inc. is a healthcare technology company based in San Francisco, California, with additional offices in Menlo Park and Dhaka, Bangladesh. Founded in 2012, Augmedix specializes in remote medical documentation and live clinical support through its cloud-based platform. The application transforms natural clinician-patient conversations into organized medical notes in real time, allowing healthcare providers to focus more on patient care and reducing the administrative burden associated with electronic health record documentation. By partnering with hospitals and health systems, Augmedix enhances clinical efficiency and decision-making, ultimately improving operational and financial outcomes. The platform is designed for use by both large healthcare organizations and individual practitioners, charging service fees for access to its remote documentation and clinical support services.

Parsley Health, Inc. offers personalized holistic healthcare services focused on addressing the root causes of diseases. By considering patients' personal histories, lifestyles, environments, and genetic factors, the company creates comprehensive health regimens that may include dietary changes, lifestyle adjustments, stress management techniques, supplements, botanical medicines, and prescription drugs. Their services encompass functional medicine assessments, personalized nutrition consultations, health coaching, specialized testing, bioidentical hormone therapy, and online access to labs and medical records. Parsley Health also provides various diagnostic tests and sells health-related products online. Founded in 2015 by Dr. Robin Berzin, M.D., the company operates clinics in New York City, Los Angeles, and San Francisco, integrating technology with wellness and preventive care to offer a subscription-based model that emphasizes chronic disease management and personalized treatment.

Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

RoundTrip is disrupting the medical transportation industry by providing on-demand medical transportation for hospitals, healthcare organizations, transportation organizations, and health plans.They get the ins and outs of care coordination because they started as paramedics and EMTs before earning MBAs and executive positions at some of the largest healthcare and medical transportation companies in the world. RoundTrip schedules, dispatches, and monitors non-emergency transportation for organizations and their riders in ten states. A few of their major partners include Mount Sinai Health System, Cooper University Health System, MD Anderson Cancer Center at Cooper, Nemours Children’s Hospital, Crozer-Keystone Health System, and GRTC (the government paratransit program) of Richmond and Henrico Counties, VA. It offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT).

Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Banyan is a digital marketing and patient engagement platform dedicated to enhancing the connection between healthcare professionals and patients. Founded in 2013 and based in Orem, Utah, Banyan offers a HIPAA-compliant media consent application that allows medical practices to share authorized patient photos on social media platforms such as Facebook, Instagram, and Twitter. The platform further supports healthcare providers by facilitating online reviews through a streamlined request tool and ensuring accurate practice information across over 70 web directories. Banyan also provides personalized websites to establish credibility for practices and offers coaching to help clients strengthen their brands, improve search engine optimization, and increase patient acquisition and retention. Operating as a subsidiary of NUVI LLC since 2019, Banyan focuses on helping healthcare clients foster a more humanized approach to patient care through effective online engagement.

American Gene Technologies (AGT) specializes in developing innovative gene therapies aimed at curing serious diseases, including infectious diseases, cancers, and inherited disorders. The company is advancing its proprietary gene-delivery platform, which is backed by multiple patents, including those for its AGT103-T cell product designed to functionally cure HIV. AGT is also focused on a unique immuno-oncology approach that stimulates gamma-delta T cells to target various solid tumors. Additionally, the company has developed a synthetic gene to provide effective treatments for Phenylketonuria (PKU). AGT’s clinical trial for an HIV cure has the potential to not only address a significant public health challenge but also validate its technology platform for treating a variety of diseases.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Scene Health, formerly known as Emocha Health, addresses the longstanding issue of medication nonadherence by utilizing a comprehensive approach that combines technology, education, and personalized support. The company offers a mobile app that facilitates daily video check-ins, allowing patients to connect with healthcare professionals, including pharmacists and nurses, from anywhere at any time. This innovative platform enhances the traditional Directly Observed Therapy model by providing personalized video coaching and motivational content, thereby engaging patients and their families in their health management. Scene Health's solutions are designed to tackle the $500 billion medication nonadherence problem by identifying and addressing barriers related to social determinants of health. With over 120 clients in the healthcare sector, Scene Health aims to improve medication adherence for patients with chronic and infectious diseases, ultimately enhancing public health outcomes and reducing healthcare costs associated with nonadherence.

Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.